Published in Proc Natl Acad Sci U S A on June 23, 1998
Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's Disease | NCT00783575
Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun (2000) 5.65
CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet (2002) 5.31
Negative epistasis between the malaria-protective effects of alpha+-thalassemia and the sickle cell trait. Nat Genet (2005) 4.22
A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am J Hum Genet (2001) 4.17
Genomewide scans of complex human diseases: true linkage is hard to find. Am J Hum Genet (2001) 3.70
Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet (2008) 3.54
Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet (2000) 3.52
A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet (1999) 2.88
Genetic analyses of chromosome 12 loci in Crohn's disease. Gut (2000) 2.30
Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev (2002) 2.29
Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis. Mucosal Immunol (2008) 2.28
Synthetic associations are unlikely to account for many common disease genome-wide association signals. PLoS Biol (2011) 2.00
HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut (1999) 1.94
Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2. Gut (2005) 1.84
Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm Bowel Dis (2010) 1.79
Genome-wide meta-analysis for rheumatoid arthritis. Hum Genet (2006) 1.75
CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. Am J Hum Genet (2002) 1.74
Testing an 'aging gene' in long-lived drosophila strains: increased longevity depends on sex and genetic background. Aging Cell (2003) 1.64
The IL23 axis plays a key role in the pathogenesis of IBD. Gut (2007) 1.58
Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet (1999) 1.57
High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12. Am J Hum Genet (2000) 1.52
Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31. Gut (2003) 1.42
Analysis of the IBD5 locus and potential gene-gene interactions in Crohn's disease. Gut (2003) 1.31
A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice. Proc Natl Acad Sci U S A (2001) 1.30
Radical induction theory of ulcerative colitis. World J Gastroenterol (2005) 1.28
MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet (2003) 1.26
Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia. Proc Natl Acad Sci U S A (2004) 1.24
TNFSF15 is an ethnic-specific IBD gene. Inflamm Bowel Dis (2007) 1.24
Fine mapping of the chromosome 3p susceptibility locus in inflammatory bowel disease. Gut (2001) 1.23
Identification of a novel psoriasis susceptibility locus at 1p and evidence of epistasis between PSORS1 and candidate loci. J Med Genet (2001) 1.23
The genetic jigsaw of inflammatory bowel disease. Gut (2002) 1.20
Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p. Proc Natl Acad Sci U S A (2001) 1.17
Genome wide scan in a Flemish inflammatory bowel disease population: support for the IBD4 locus, population heterogeneity, and epistasis. Gut (2004) 1.17
Crohn disease: frequency and nature of CARD15 mutations in Ashkenazi and Sephardi/Oriental Jewish families. Am J Hum Genet (2004) 1.17
SAMP1/YitFc mouse strain: a spontaneous model of Crohn's disease-like ileitis. Inflamm Bowel Dis (2011) 1.17
Statistical modeling of interlocus interactions in a complex disease: rejection of the multiplicative model of epistasis in type 1 diabetes. Genetics (2001) 1.12
IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease. J Clin Immunol (2000) 1.05
The IBD2 locus shows linkage heterogeneity between ulcerative colitis and Crohn disease. Am J Hum Genet (2000) 1.01
Diagnostic misclassification reduces the ability to detect linkage in inflammatory bowel disease genetic studies. Gut (2001) 0.99
Progress in searching for susceptibility gene for inflammatory bowel disease by positional cloning. World J Gastroenterol (2003) 0.97
Molecular-phylogenetic characterization of the microbiota in ulcerated and non-ulcerated regions in the patients with Crohn's disease. PLoS One (2012) 0.94
Genetic studies of Crohn's disease: past, present and future. Best Pract Res Clin Gastroenterol (2014) 0.94
Cdcs1 a major colitis susceptibility locus in mice; subcongenic analysis reveals genetic complexity. Inflamm Bowel Dis (2010) 0.93
Meta-analysis of genome-wide linkage studies across autoimmune diseases. Eur J Hum Genet (2008) 0.92
Familial aggregation in inflammatory bowel disease: is it genes or environment? World J Gastroenterol (2011) 0.92
The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease. Tissue Barriers (2013) 0.91
MAST3: a novel IBD risk factor that modulates TLR4 signaling. Genes Immun (2008) 0.90
Prevalence of SLC22A4, SLC22A5 and CARD15 gene mutations in Hungarian pediatric patients with Crohn's disease. World J Gastroenterol (2006) 0.87
CARD15/NOD2 in a Tunisian population with Crohn's disease. Dig Dis Sci (2005) 0.85
Search for haplotype interactions that influence susceptibility to type 1 diabetes, through use of unphased genotype data. Am J Hum Genet (2003) 0.84
Angiotensinogen and transforming growth factor beta1: novel genes in the pathogenesis of Crohn's disease. J Med Genet (2006) 0.84
No association of the NFKB1 promoter polymorphism with ulcerative colitis in a British case control cohort. Gut (2005) 0.84
Genetic evidence supporting the association of protease and protease inhibitor genes with inflammatory bowel disease: a systematic review. PLoS One (2011) 0.82
Current understanding of fungal microflora in inflammatory bowel disease pathogenesis. Inflamm Bowel Dis (2008) 0.82
Novel susceptibility genes in inflammatory bowel disease. World J Gastroenterol (2006) 0.81
Risk association between the NF-κB1 -94ins/delATTG promoter polymorphism and inflammatory bowel diseases: a meta-analysis. Dig Dis Sci (2012) 0.81
The RUNX complex: reaching beyond haematopoiesis into immunity. Immunology (2015) 0.81
The 3'UTR NFKBIA variant is associated with extensive colitis in Hungarian IBD patients. Dig Dis Sci (2008) 0.80
Tumor necrosis factor receptor superfamily, member 1B haplotypes increase or decrease the risk of inflammatory bowel diseases in a New Zealand caucasian population. Gastroenterol Res Pract (2009) 0.80
No association of the cytotoxic T-lymphocyte associated gene CTLA4 +49A/G polymorphisms with Crohn's disease and ulcerative colitis in Hungarian population samples. World J Gastroenterol (2007) 0.79
Immune diseases caused by mutations in kinases and components of the ubiquitin system. Nat Immunol (2014) 0.79
Unravelling the complex genetics of inflammatory bowel disease. Arch Dis Child (2004) 0.78
Genomic Scans of Zygotic Disequilibrium and Epistatic SNPs in HapMap Phase III Populations. PLoS One (2015) 0.78
An SNP linkage scan identifies significant Crohn's disease loci on chromosomes 13q13.3 and, in Jewish families, on 1p35.2 and 3q29. Genes Immun (2008) 0.78
Assessing the joint effect of population stratification and sample selection in studies of gene-gene (environment) interactions. BMC Genet (2012) 0.77
Quasi-linkage: a confounding factor in linkage analysis of complex diseases? Hum Genet (2004) 0.77
Ste20-related proline/alanine-rich kinase: a novel regulator of intestinal inflammation. World J Gastroenterol (2008) 0.77
Stratification by CARD15 variant genotype in a genome-wide search for inflammatory bowel disease susceptibility loci. Hum Genet (2003) 0.76
NOD2 polymorphisms in clinical phenotypes of common variable immunodeficiency disorders. Clin Exp Immunol (2010) 0.75
Bayesian Machine Learning Techniques for revealing complex interactions among genetic and clinical factors in association with extra-intestinal Manifestations in IBD patients. AMIA Annu Symp Proc (2017) 0.75
-449 C>G polymorphism of NFKB1 gene, coding nuclear factor-kappa-B, is associated with the susceptibility to ulcerative colitis. World J Gastroenterol (2012) 0.75
Uncovering Pathogenic Mechanisms of Inflammatory Bowel Disease Using Mouse Models of Crohn's Disease-Like Ileitis: What is the Right Model? Cell Mol Gastroenterol Hepatol (2017) 0.75
Genotype and phenotype relation in inflammatory bowel disease. J Gastroenterol (2005) 0.75
Identification of genetic loci for basal cell nevus syndrome and inflammatory bowel disease in a single large pedigree. Hum Genet (2006) 0.75
Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet (1995) 49.77
Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet (1996) 39.80
Genetic dissection of complex traits. Science (1994) 29.54
Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet (1997) 13.93
The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet (1996) 11.61
Inflammatory bowel disease (1) N Engl J Med (1991) 5.78
Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature (1996) 5.44
Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet (1996) 4.09
Familial occurrence of inflammatory bowel disease. N Engl J Med (1991) 2.95
Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut (1993) 2.35
Improved set of short-tandem-repeat polymorphisms for screening the human genome. Am J Hum Genet (1997) 2.03
Sets of short tandem repeat polymorphisms for efficient linkage screening of the human genome. Hum Mol Genet (1995) 1.99
Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis. Hum Mol Genet (1996) 1.93
Epidemiology of inflammatory bowel disease. Epidemiol Rev (1986) 1.84
The genetics of inflammatory bowel disease. Gut (1997) 1.83
Incidence of inflammatory bowel disease in northern France (1988-1990). Gut (1994) 1.81
Chronic ulcerative colitis: incidence and prevalence in a community. Gut (1987) 1.66
Jewish diseases and origins. Nat Genet (1995) 1.65
Susceptibility loci in inflammatory bowel disease. Lancet (1996) 1.49
The genetics of Crohn disease: complex segregation analysis of a family study with 265 patients with Crohn disease and 5,387 relatives. Am J Med Genet (1989) 1.48
Genetic analysis of NIDDM. The study of quantitative traits. Diabetes (1996) 1.40
Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis. BMJ (1993) 1.34
Comparison of fluorescence-based semi-automated genotyping of multiple microsatellite loci with autoradiographic techniques. Genomics (1994) 1.30
Multiple loci for multiple sclerosis. Nat Genet (1996) 1.14
Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease. G.E.T.A.I.D. Am J Med Genet (1994) 1.02
Analysis of the contribution of HLA genes to genetic predisposition in inflammatory bowel disease. Am J Hum Genet (1996) 0.99
Indeterminate colitis in the spectrum of inflammatory bowel disease. Arch Pathol Lab Med (1979) 0.94
Confirmation of a susceptibility locus for Crohn's disease on chromosome 16. Inflamm Bowel Dis (1997) 0.92
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 28.24
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med (1997) 10.67
Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med (1995) 8.23
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis (2000) 6.90
HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA (1989) 6.68
Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med (1999) 6.24
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet (2001) 4.97
Compilation of tRNA sequences and sequences of tRNA genes. Nucleic Acids Res (1989) 4.79
The initiation sites for RNA transcription in Ad2 DNA. Cell (1977) 4.76
Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J Virol (1996) 4.43
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial. Gut (2007) 4.21
The definition of a large viral transcription unit late in Ad2 infection of HeLa cells: mapping by effects of ultraviolet irradiation. Cell (1977) 4.13
Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr (1991) 4.11
Is clearance of HIV-1 viraemia at seroconversion mediated by neutralising antibodies? Lancet (1992) 4.05
Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nat Genet (1999) 3.95
Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology (2001) 3.85
Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat Genet (1997) 3.70
Organization of intrahippocampal projections originating from CA3 pyramidal cells in the rat. J Comp Neurol (1990) 3.67
Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci U S A (2000) 3.44
Preliminary evidence for genetic anticipation in Crohn's disease. Lancet (1996) 3.32
The definition of a large viral transcription unit late in Ad2 infection of HeLa cells: mapping of nascent RNA molecules labeled in isolated nuclei. Cell (1977) 3.32
Susceptibility testing of Cryptococcus neoformans: a microdilution technique. J Clin Microbiol (1992) 3.12
Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron (1998) 3.08
Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet (2000) 3.04
Lymphocytic ("microscopic") colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol (1989) 3.02
kat: a high-efficiency retroviral transduction system for primary human T lymphocytes. Blood (1994) 2.94
Intestinal ulceration--a complication of celiac disease. N Engl J Med (1967) 2.90
Genetic analysis of adenovirus type 2 III. Temperature sensitivity of processing viral proteins. J Virol (1976) 2.88
Collagenous colitis with mucosal tears on endoscopic insufflation: a unique presentation. Gut (2002) 2.81
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis (2001) 2.80
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. N Engl J Med (2000) 2.78
HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS. Am J Pathol (1986) 2.77
NMR structure of the histidine kinase domain of the E. coli osmosensor EnvZ. Nature (1998) 2.69
Enhanced cellulase production by a mutant of Trichoderma viride. Appl Microbiol (1971) 2.67
Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study. Gastroenterology (1989) 2.66
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. Gastroenterology (1999) 2.62
Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics (1992) 2.55
Use of azathioprine or 6-mercaptopurine in the treatment of Crohn's disease. Gastroenterology (1991) 2.55
Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. Inflamm Bowel Dis (1999) 2.55
Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat Genet (1995) 2.51
Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology (1996) 2.50
Histidine kinases: diversity of domain organization. Mol Microbiol (1999) 2.47
Regional localization of DNA sequences on chromosome 21 using somatic cell hybrids. Am J Hum Genet (1986) 2.45
The role of the adenovirus protease on virus entry into cells. EMBO J (1996) 2.44
Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. J Rheumatol (1994) 2.43
Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 2.41
Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol (2001) 2.39
Animal models of drug craving. Psychopharmacology (Berl) (1993) 2.32
PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. Proc Natl Acad Sci U S A (1994) 2.29
Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis. Mucosal Immunol (2008) 2.28
Clinical spectrum of fibroblast growth factor receptor mutations. Hum Mutat (1999) 2.24
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group. Gastroenterology (2000) 2.23
Risky business: health and safety in the sex industry over a 9 year period. Sex Transm Infect (1999) 2.22
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group. Gastroenterology (2000) 2.21
Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J Biol Chem (1994) 2.20
Identification and characterization of a novel related adhesion focal tyrosine kinase (RAFTK) from megakaryocytes and brain. J Biol Chem (1995) 2.17
Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology (1998) 2.15
Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial. Gastroenterology (1999) 2.15
Prevalence of HIV infection in patients attending an inner city accident and emergency department. BMJ (1994) 2.15
The use of Medpor coated tear drainage tube in conjunctivodacryocystorhinostomy. Eye (Lond) (2007) 2.13
P-glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site. J Biol Chem (1995) 2.12
Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease. Aliment Pharmacol Ther (2013) 2.12
Pretransplant IgG reactivity to apoptotic cells correlates with late kidney allograft loss. Am J Transplant (2014) 2.09
Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell (1994) 2.05
Lower regional and temporal ultraviolet exposure is associated with increased rates and severity of inflammatory bowel disease hospitalisation. Aliment Pharmacol Ther (2014) 2.04
Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23-24.1. Nat Genet (1993) 2.03
Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group. Gastroenterology (1993) 2.03
P-selectin/ICAM-1 double mutant mice: acute emigration of neutrophils into the peritoneum is completely absent but is normal into pulmonary alveoli. J Clin Invest (1995) 2.02
MRI atlas of the human cerebellar nuclei. Neuroimage (2002) 2.00
Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology (1992) 1.98
Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science (1998) 1.97
Chronic colitis with thickening of the subepithelial collagen layer (collagenous colitis): histopathologic findings in 15 patients. Hum Pathol (1987) 1.97
Evidence for a genetic aetiology in reading disability of twins. Nature (1987) 1.92
Intravenous cyclosporin in ulcerative colitis: a five-year experience. Am J Gastroenterol (1999) 1.90
Characterization of a cloned DNA sequence that is present at centromeres of all human autosomes and the X chromosome and shows polymorphic variation. Proc Natl Acad Sci U S A (1984) 1.86
Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome. Am J Hum Genet (2000) 1.85
Analysis of phenotypic features and FGFR2 mutations in Apert syndrome. Am J Hum Genet (1995) 1.85
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group. Gastroenterology (1999) 1.84
Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype--phenotype correlation. Hum Mol Genet (2001) 1.84
Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans. J Biol Chem (1998) 1.84
Sexual partner networks in the transmission of sexually transmitted diseases. An analysis of gonorrhea cases in Sheffield, UK. Sex Transm Dis (1997) 1.82
Nosocomial pneumonia caused by carbapenem-resistant Raoultella planticola: a case report and literature review. Infection (2015) 1.82
Mesenteric lymphadenitis and terminal ileitis due to yersinia pseudotuberculosis. N Engl J Med (1970) 1.82
Cloning and sequencing of a rabbit cDNA encoding an intestinal and kidney-specific Na+/H+ exchanger isoform (NHE-3). J Biol Chem (1992) 1.81
Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res (2000) 1.80
Advancing age has differential effects on DNA damage, chromatin integrity, gene mutations, and aneuploidies in sperm. Proc Natl Acad Sci U S A (2006) 1.80
Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: the role of microglia, phagocytosis, and NADPH oxidase. FASEB J (2004) 1.79
Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine. Aliment Pharmacol Ther (2005) 1.79
Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol. J Pharmacol Exp Ther (1992) 1.76
Phosphatase activity of histidine kinase EnvZ without kinase catalytic domain. Proc Natl Acad Sci U S A (2000) 1.75
Surgical management of Crohn's disease. Influence of disease at margin of resection. Ann Surg (1980) 1.75
HTLV-1 infection in tropical spastic paraparesis: lymphocyte culture and serologic response. AIDS Res Hum Retroviruses (1988) 1.74